Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,372.00
(
0.05%
)
Dow Jones
49,526.17
(
0.00%
)
Brent Oil
106.09
(
-1.29%
)
Bitcoin
77,270.44
(
-0.18%
)
News Focus
News Focus
Post# of 518521
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

attilathehunt

Send PM Follow Ignore
Followers 71
Posts 9073
Boards Moderated 0
Alias Born 03/06/2016

attilathehunt

Re: powerwalker post# 319631

Monday, 07/05/2021 10:24:54 AM

Monday, July 05, 2021 10:24:54 AM

Post# of 518521
Anavex Life Sciences Receives TGA Special Access Scheme Approval for ANAVEX®2-73 (blarcamesine) for Alzheimer’s Disease Patients


Remember this?....Eleven months ago today....

I wonder how this will play out with the recent Rett and PDD data?

Will the TGA make another move?

"We hold FTD, RPDD, and ODD for Rett." Coupled with clinically meaningful & statistically significant data will move the FDA to AA...What's the point in issuing these designations if clinically meaningful and stat sig data isn't enough? Approval in 3 mo

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News